Corient Private Wealth
ONC

Corient Private Wealth’s BeOne Medicines Ltd ONC Stock Holding History

Corient Private Wealth’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$323K Buy
1,132
+127
+13% +$37.4K ﹤0.01% 2515
2026
Q1 		$295K Sell
1,005
-64
-6% -$20.7K ﹤0.01% 2325
2025
Q4 		$325K Buy
1,069
+224
+27% +$73.3K ﹤0.01% 2120
2025
Q3 		$288K Buy
+845
New +$257K ﹤0.01% 2147

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Corient Private Wealth's ONC Position: Q2 2026 in Review

Corient Private Wealth increased its BeOne Medicines Ltd (ONC) stake by 13% in Q2 2026, buying an estimated $37.4K and bringing the position to 1,132 shares worth $323K. The position accounts for ﹤0.01% of the portfolio, ranked #2515.

Corient Private Wealth first reported a position in ONC in Q3 2025 and has held it in 4 quarters since. The position peaked at $325K in Q4 2025. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Corient Private Wealth held 1,132 shares of BeOne Medicines Ltd worth $323K as of Q2 2026.
  • Corient Private Wealth bought 127 BeOne Medicines Ltd shares in Q2 2026, an estimated $37.4K.
  • BeOne Medicines Ltd made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2515 holding.
  • Corient Private Wealth first reported a position in BeOne Medicines Ltd in Q3 2025 and has held it in 4 quarters since.
  • Corient Private Wealth's BeOne Medicines Ltd position peaked at $325K in Q4 2025.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.